Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesis. - Nann D; Schade TC; Overkamp M; Mahmutovic L; Bag E; Forchhammer S; Slotta-Huspenina J; Boudova L; Sotlar K; Quintanilla-Martinez L; Bonzheim I; Fend F (The journal of pathology. Clinical research, 2025)